| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81946deb058c0de9877baab02952cec4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 |
| filingDate |
2006-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48a8f5fff3f694c8abe5ec72de4ae107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_120975be645358e4b1307e9420d2d174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_144d78867e01628d14beb192958f6a0e |
| publicationDate |
2008-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008255097-A1 |
| titleOfInvention |
Methods for the Treatment of Substance Abuse and Dependence |
| abstract |
The present invention relates to methods of and compositions for treating and relieving symptoms and disease associated with indications caused by a physiological drive to alleviate a sensation of anxiety. More specifically, the present invention relates to methods of and compositions for treating and relieving symptoms associated with substance abuse and withdrawal. The present invention relates to methods of and compositions for treating and relieving symptoms associated with addiction to antidepressants, opiates, nicotine or marijuana. In one method, a patient is treated with a composition that directly or indirectly modulates GABA A by modulating the expression of the GABA A receptor a 4 subunit. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011159048-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8202525-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8617577-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372414-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8741319-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008280885-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8012958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011073985-A1 |
| priorityDate |
2005-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |